Smith Matthew R MR

Show results for

Unknown (41)
Genomics (13)
Proteomics (4)
Metabolomics (4)
Transcriptomics (1)

Organisms

Homo sapiens (13)
Mus musculus (1)
Alphavirus (1)
Anemia (1)
Archaea (1)
Bacteria (1)
Betaherpesvirinae (1)
Borrelia (1)
Chlamydomonas reinhardtii (1)
Chlorella vulgaris (1)
Clostridium perfringens (1)
Dengue virus (1)
Eukaryota (1)
Hepatitis B virus (1)
Human alphaherpesvirus 1 (1)
Human betaherpesvirus 5 (1)
Influenza A virus (1)
Influenza C virus (1)
Japanese encephalitis virus group (1)
Kamptonema sp. (1)
Listeria monocytogenes (1)
Mammarenavirus (1)
Miscanthus x giganteus (1)
Mycobacterium tuberculosis (1)
Orthoflavivirus (1)
Pseudomonas aeruginosa (1)
Rattus (1)
Sarbecovirus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Staphylococcus aureus (1)

Repository

EGA (13)
MetaboLights (4)
MassIVE (3)
biostudies-arrayexpress (1)
pride (1)

Disease

Disease free (1)

Technology Type

Illumina 15K (8)
Mass spectrometry (3)
NMR spectroscopy (1)
Mass spectrometry assay (1)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
LTQ Orbitrap Velos (2)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS - positive - reverse phase (2)
ImpactHD (Bruker Daltonics) (1)
LTQ (1)
LTQ FT (1)
LTQ Orbitrap (1)
Q Exactive (1)
Exactive (Thermo Scientific) (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2023 (2)
2022 (2)
2009 (1)
2019 (1)
2017 (1)
2015 (1)
2018 (1)

CHEBI ID

CHEBI:17626 (2)
CHEBI:28044 (2)
CHEBI:18123 (2)
CHEBI:46195 (2)
CHEBI:25998 (2)
CHEBI:17405 (2)
CHEBI:48131 (2)
CHEBI:32805 (2)
CHEBI:35280 (2)
CHEBI:27897 (2)
CHEBI:80723 (1)
CHEBI:31297 (1)
CHEBI:10086 (1)
CHEBI:80541 (1)
CHEBI:31826 (1)
CHEBI:34985 (1)
CHEBI:34983 (1)
CHEBI:1720 (1)
CHEBI:1182 (1)
CHEBI:79694 (1)
CHEBI:79480 (1)
CHEBI:79904 (1)
CHEBI:79869 (1)
CHEBI:31825 (1)
CHEBI:9390 (1)
CHEBI:7776 (1)
CHEBI:4816 (1)
CHEBI:3575 (1)
CHEBI:27670 (1)
CHEBI:8770 (1)

Metabolite Name

Trigonelline (2)
(3beta,4alpha,5alpha)-3-Hydroxy-4-methylcholest-7-ene-4-carboxylic acid (1)
(1S)-1-{(2R,3R,5R)-5-Hydroxy-3-[(3beta,5alpha,13alpha,14beta,17alpha)-3-hydroxy-4,4,14-trimethylandrost-7-en-17-yl]tetrahydro-2-furanyl}-2-methyl-1,2-propanediol (1)
(8alpha,9beta,11beta,14beta,20S,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one (1)
1-[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Hydroxy-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethylicosahydro-1H-cyclopenta[a]chrysen-1-yl]ethanone (1)
Theasapogenol b (1)
(6R)-6-[(1E,3Z,5R,7E,9E,11R,13S,14R,15S)-3-Ethyl-14-hydroxy-5,9,11,13,15-pentamethyl-12-oxo-1,3,7,9-heptadecatetraen-1-yl]-5,6-dihydro-2H-pyran-2-one (1)
E-Tokoferol (1)
Bolandiol dipropionate (1)
(2S)-2-(4-Isobutylphenyl)propanoic acid - L-lysine hydrate (1:1:1) (1)
Yamogenin (1)
(5beta)-14-Hydroxycholest-7-ene-3,6-dione (1)
Metenolone enanthate (1)
10-[(1R,2S)-2-Hexylcyclopropyl]decanoic acid (1)
METHYL OLEATE (1)
(6Z)-17-Methyl-6-octadecenoic acid (1)
Nisobamate (1)
(3beta,5beta,6beta,7alpha,22E,24xi)-5,19-Cycloergost-22-ene-3,6,7-triol (1)
(3beta,6beta,7alpha,22E,24xi)-Ergosta-4,22-diene-3,6,7-triol (1)
(3beta,7beta,22E,24xi)-Ergosta-5,22-diene-3,7,8-triol (1)
(3beta,4alpha,5alpha)-3-Hydroxycholest-7-ene-4-carboxylic acid (1)
(14xi,22R,23R,24S)-22,23-Dihydroxyergost-4-en-3-one (1)
(2S)-2-Aminotridecanoic acid (1)
(3alpha,5beta)-3,17,21-Trihydroxypregnan-20-one (1)
3a,11b,21-Trihydroxy-5b-pregnan-20-one (1)
Drostanolone (1)
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid (1)
(4aS,8S,8aS)-8-[(3S)-3-Hydroxy-3-methyl-4-penten-1-yl]-4,4,8a-trimethyl-7-methyleneoctahydro-2(1H)-naphthalenone (1)
Acutilol A (1)
(3alpha)-3,20,21-Trihydroxypregnan-11-one (1)

Study type

Transcription profiling by array (1)

Release Date

2020 (18)
2024 (4)
2021 (4)
2023 (3)
2025 (2)
2022 (2)
2014 (2)
2013 (2)
2009 (1)
2018 (1)
2016 (1)
2012 (1)
2007 (1)

Lab affiliation

Woods Hole Oceanographic Institution USA (1)

Previous page
1 / 7
You're on page 1
page 2
page 3
page 4
page 5
page 6
page 7
Next page

Sort by:

Relevance

Page size

Sarcopenia during androgen-deprivation therapy for prostate cancer.

Not available

S-EPMC3434987 | biostudies-literature

Metabolic phenotyping of urine from a dementia research cohort

To better understand the molecular mechanisms underpinning physiological variation in human populations, metabolic phenotyping approaches are increasingly being applied to studies involving hundreds and thousands of biofluid samples. Hyphenated ultra-performance liquid chromatography-mass spectromet...

2022-03-01 | MTBLS719 | MetaboLights

Antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19

BACKGROUND: There is a critical need for rapid viral infection diagnostics to enable prompt case identification in pandemic settings and support targeted antimicrobial prescribing.

METHODS: Using untargeted high-resolution liquid chromatography coupled with...

2022-02-10 | MTBLS718 | MetaboLights

Zfx controls BCR-induced proliferation and survival of B lymphocytes

The development, homeostasis and function of B lymphocytes involve multiple rounds of B cell receptor (BCR)-controlled proliferation and prolonged maintenance. We analyzed the role of transcription factor Zfx, a recently identified regulator of stem cell maintenance, in B cell development and homeos...

ORGANISM(S): Mus musculus

2009-04-16 | E-GEOD-13547 | biostudies-arrayexpress

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials.

Not available

S-EPMC5815402 | biostudies-literature

Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.

Not available

S-EPMC3795889 | biostudies-literature

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.

Not available

S-EPMC4383838 | biostudies-literature

Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).

Not available

S-EPMC3970172 | biostudies-literature

Dynamic metabolic efficiency of substrate utilization by copiotrophic marine bacteria

Under well-defined laboratory conditions, we grew R. pomeroyi DSS-3 and A. macleodii MIT1002 in batch cultures on a monosaccharide (glucose) and organic acid (acetate), provided either individually or in combination, and all at the same carbon equivalent. This batch culturing approach mimicked bacte...

ORGANISM(S): Alteromonas macleodii Ruegeria pomeroyi DSS-3 Bacteria

2023-10-27 | PXD045824 | Pride

Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.

Not available

S-EPMC4110249 | biostudies-literature

Previous page
1 / 7
You're on page 1
page 2
page 3
page 4
page 5
page 6
page 7
Next page

Sort by:

Relevance

Page size

63 Results

Show results for

Organisms

Repository

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets